Hepatitis E: Epidemiology and prevention.

Area of Science:

• Hepatology
• Virology
• Infectious Diseases

Background:

• Hepatitis E virus (HEV) is a primary cause of enterically transmitted non-A hepatitis globally.
• HEV outbreaks are prevalent in developing regions of Africa and Asia, with genotype 1 being a major contributor.
• Genotype 3 HEV is increasingly recognized as a significant pathogen in developed countries.

Purpose of the Study:

• To summarize the epidemiology, clinical features, diagnosis, and current management of Hepatitis E.
• To highlight the distinct high mortality associated with HEV in pregnant women.

Main Methods:

• Review of HEV epidemiology, clinical presentation, and diagnostic methods.
• Analysis of HEV genotypes and their geographical distribution.
• Assessment of current treatment and vaccine development status.

Main Results:

• HEV is a non-enveloped, single-stranded RNA virus of the Hepeviridae family, with four genotypes.
• Clinical presentation is often indistinguishable from other hepatitis viruses, except for high maternal mortality in the third trimester.
• Diagnosis relies on serological tests or viral nucleic acid detection via RT-PCR.

Conclusions:

• HEV poses a significant global health challenge, particularly in developing countries and increasingly in developed nations.
• Early diagnosis and supportive care are crucial for managing acute Hepatitis E.
• While vaccine candidates exist, none are currently approved, and specific antiviral therapies are lacking.